Owen Wild is Deputy Editor of International Financing Review based in London and also has global responsibility for equity capital markets coverage. Prior to 2010 he was associate editor for equities and structured equity. Owen joined IFR in 2004 as a reporter and has since worked across Equities, Structured Equity and Derivatives sections as both reporter and editor. Before joining IFR, Owen covered foreign exchange markets. Follow Owen on Twitter @IFR_Owen
- +44 (0)20 7542 8541
Bayer’s US$66bn acquisition of Monsanto required an enormous fundraising effort across asset classes. Each slice was market-defining, but the company’s deft strategy meant that each was easily absorbed by an enthusiastic investor base. Bayer is IFR’s Corporate Issuer of the Year.
Every equity-linked deal led by UBS was unique and met a client’s specific need. Not wedded to one style, UBS mixed features and adapted structures with flair and is IFR’s EMEA Structured Equity House of the Year.
Equity House, Asia-Pacific Equity House, North America Equity House and Latin America Equity House: Goldman Sachs
Goldman Sachs was on the offense as it charged down the opposition to reclaim lost ground. For leading bold deals, operating across borders and reacting to tougher markets, Goldman Sachs is IFR’s Equity House, Asia-Pacific Equity House, North America Equity House and Latin America Equity House of the Year.